🇪🇺 Starlix in European Union

Starlix (NATEGLINIDE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000335
  • Local brand name: Starlix
  • Status: withdrawn

Starlix in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Starlix approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Starlix in European Union?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.